Macroaxis: Personalized Investing
Simple Personalized Investing

WAT TRMB GRMN CGG Sport Products Communication Money Market Market Drivers 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for BIO

BioRad quote and profile

 
 Companies |  Insiders  | Dashboard  
     
115.07
  
STOCK
(0.50)  Macroaxis: -0.43 Down   0.43%  
Year To Date
91.52127
Last 1 Month(s)
112121
Trading Day 
114116
May 25 2013 

Diversification Suggestion

Use BioRad to protect against small markets fluctuations. The stock experiences normal downward trend and little activity
Analyze BioRad Laboratories Trend or Check current 30 days BioRad correlation with market (S&P 500)
1 Month Beta 0.58  
Highest Price:  
Lowest Price:  
120.75  
111.66  
May 03 2013 
May 07 2013 
As returns on market increase, BioRad returns are expected to increase less than the market. However during bear market, the loss on holding BioRad will be expected to be smaller as well.
BioRad Laboratories Inc Small BetaBioRad Laboratories Beta Legend
BIO United States NYSE
BioRad Laboratories Inc
Technology
Scientific and Technical Instruments
Benchmark S&P 500
http://www.bio-rad.com
Contact Number: 510. 724. 7000
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation3.21 B
Shares Outstanding28.53 M
Number of Shares Shorted142.58 K
Revenue2.08 B
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States Russel   0.00 % No Change  
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
 United States NYSE   0.25 % Macroaxis: 0.25 Moved Down  
 
 thisRed BIO BIO agains markets  0.43 % Macroaxis: 0.43 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

BioRad Leadership

Norman Schwartz Chairman, CEO and Pres
David Schwartz Chairman of the Board
Bradford Crutchfield Executive VP and President of The Life Science Group
John Goetz Executive VP and President of The Clinical Diagnostics Group

BioRad Price and Market Media

The median price of BioRad for the period between Thu, Apr 25, 2013 and Sat, May 25, 2013 is 117.57 with a coefficient of variation of 1.81. The daily time series for the period is distributed with a sample standard deviation of 2.13, arithmetic mean of 117.41, and mean deviation of 1.63. The Stock received substential amount of media coverage during this period.
BioRad         SP 500
Price Growth (%)
 
1
Global Transfection Gene Delivery DNA Delivery Protein Deliv...04/26/2013Macroaxis: News
2
Global Proteomics Market Industry Key Trends Growth Drivers ...05/01/2013Macroaxis: News
3
BioRad Laboratories Q1 13 Earnings Conference Call At 500 PM...05/09/2013Macroaxis: News
4
BioRad Named One of the 39Best Places to Work 201339 in the ...05/14/2013Macroaxis: News
5
Will Google Throw In The Towel In The Endgame Against Vringo...05/23/2013Macroaxis: Seeking Alpha News

BioRad Summary

BioRad Laboratories Inc [BIO] is traded on New York Stock Exchange in USA. It is located in BioRad Laboratories, Inc.Hercules, CA and employs 7,380 people. The company currently falls under 'Mid-Cap' category with total capitalization of 3.29 B. BioRad Laboratories Inc runs under Technology sector within Scientific and Technical Instruments industry. This company has 28.53 M outstanding shares of which 142.58 K shares are currently shorted by investors with about 2.9 days to cover shorted positions.
BioRad Laboratories, Inc. manufactures and supplies solutions and systems used to separate complex chemical and biological materials, and to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
Less
Than
35 %
 
Follow BioRad with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add BioRad to your reader
 

BioRad Research Report

BioRad vs. Waters

Correlation analysis and fundamentals comparison between BioRad Laboratories and Waters Corp

BioRad Executives

Christine Tsingos CFO and Executive VP

BioRad Directors

Alice Schwartz Director
Albert Hillman Independent Director
Ted Love Independent Director
Louis Drapeau Independent Director
Deborah Neff Independent Director

BioRad Management

Ronald Hutton Treasurer

BioRad Fundamentals

Revenue vs Debt to Equity
Working Capital vs One Year High
Revenue vs Return On Equity
Net Income vs One Year High

BioRad vs Competition

BioRad vs. Waters Corp
BioRad vs. Trimble Navigation Limited
BioRad vs. Garmin Ltd
BioRad vs. Compagnie G
BioRad vs. Bruker Corporation
BioRad vs. FEI Company
BioRad vs. Cepheid
BioRad vs. Cognex Corporation
BioRad vs. Itron Inc

BioRad May 25 2013 Opportunity Range

Downside Deviation2.09
Information Ratio(0.18)
Maximum Drawdown8.79
Value At Risk(1.80)
Potential Upside2.17

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium